Global Transdermal Drug Patches Market Growth 2019-2024

  • ID:PD041509
  • February 2019
  • LPI (LP Information)
                          

DecisionDatabases.com offers Global Transdermal Drug Patches Market Research Report with market statistics and future prospect for the year 2019-2024. This report explores historical data, market share, sales, consumption, revenue and market dynamic resulTransdermal Drug Patchesg in high quality and precise data. The future trend and outlook are analyzed and compiled with the help of industry experts. This report offers different segment analysis based on global, regional and country level along with key players with their revenue, sales, and strategic development. The data is gathered and analyzed  through primary and secondary research based on expert interviews, white papers, journals and various other sources.

A transdermal drug patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Transdermal patches are presently being marketed which can be worn anywhere from as little as eight hours to as long as seven days, depending on their therapeutic indication.

Transdermal drug patches production has relatively high technology barrier and is technology intensive industry. Currently, there are many producing companies in the USA transdermal drug patches industry. The main market players are Noven, Mylan, Novartis and Johnson & Johnson. The production of transdermal drug patches will increase to 477482 K Units in 2016 from 340530 K Units in 2011 with average growth rate of 7.00%. USA transdermal drug patches capacity utilization rate remained at around 76.86% in 2015.

Transdermal drug patches mainly has some types, which include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch and oxybutynin transdermal patch. With medical effect of transdermal drug patches, the downstream application industries will need more transdermal drug patches products.

The major raw materials for transdermal drug patches are scopolamine, clonidine, nitroglycerin, isosorbide dinitrate, estradiol, norethindrone acetate and fentanyl, etc. Fluctuations in the price of the upstream product will impact on the production cost of transdermal drug patches, and then impact the price of transdermal drug patches. The production cost of transdermal drug patches is also an important factor which could impact the price of transdermal drug patches. The transdermal drug patches manufacturers are trying to produce many more types of transdermal drug patches for other different diseases.

According to this study, over the next five years the Transdermal Drug Patches market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Transdermal Drug Patches business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Transdermal Drug Patches market by product type, application, key manufacturers and key regions and countries.

This study considers the Transdermal Drug Patches value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.

  •  Fentanyl Transdermal Patch
  •  Nicotine Transdermal Patch
  •  Buprenorphine Transdermal Patch
  •  Clonidine Transdermal Patch
  •  Oxybutynin Transdermal Patch
  •  Others
 
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
  •  Used for Hypertension
  •  Used for Contraception
  •  Used for Analgesia
  •  Used for Smoking Cessation
  •  Used for Angina
  •  Used for Hormone Replacement

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
  •  Americas
  •  United States
  •  Canada
  •  Mexico
  •  Brazil
  •  APAC
  •  China
  •  Japan
  •  Korea
  •  Southeast Asia
  •  India
  •  Australia
  •  Europe
  •  Germany
  •  France
  •  UK
  •  Italy
  •  Russia
  •  Spain
  •  Middle East & Africa
  •  Egypt
  •  South Africa
  •  Israel
  •  Turkey
  •  GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
  •  Noven
  •  Mylan
  •  Novartis
  •  Johnson & Johnson
  •  Agile Therapeutics
  •  Teikoku Pharma USA
  •  Immune Pharmaceuticals
  •  Hercon Pharmaceuticals
  •  Pocono
  •  DURECT Corporation
  •  Xel Pharmaceuticals

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
  •  To study and analyze the global Transdermal Drug Patches consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
  •  To understand the structure of Transdermal Drug Patches market by identifying its various subsegments.
  •  Focuses on the key global Transdermal Drug Patches manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
  •  To analyze the Transdermal Drug Patches with respect to individual growth trends, future prospects, and their contribution to the total market.
  •  To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  •  To project the consumption of Transdermal Drug Patches submarkets, with respect to key regions (along with their respective key countries).
  •  To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
  •  To strategically profile the key players and comprehensively analyze their growth strategies.

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
 
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Transdermal Drug Patches Consumption 2014-2024
2.1.2 Transdermal Drug Patches Consumption CAGR by Region
2.2 Transdermal Drug Patches Segment by Type
2.2.1 Fentanyl Transdermal Patch
2.2.2 Nicotine Transdermal Patch
2.2.3 Buprenorphine Transdermal Patch
2.2.4 Clonidine Transdermal Patch
2.2.5 Oxybutynin Transdermal Patch
2.2.6 Others
2.3 Transdermal Drug Patches Consumption by Type
2.3.1 Global Transdermal Drug Patches Consumption Market Share by Type (2014-2019)
2.3.2 Global Transdermal Drug Patches Revenue and Market Share by Type (2014-2019)
2.3.3 Global Transdermal Drug Patches Sale Price by Type (2014-2019)
2.4 Transdermal Drug Patches Segment by Application
2.4.1 Used for Hypertension
2.4.2 Used for Contraception
2.4.3 Used for Analgesia
2.4.4 Used for Smoking Cessation
2.4.5 Used for Angina
2.4.6 Used for Hormone Replacement
2.5 Transdermal Drug Patches Consumption by Application
2.5.1 Global Transdermal Drug Patches Consumption Market Share by Application (2014-2019)
2.5.2 Global Transdermal Drug Patches Value and Market Share by Application (2014-2019)
2.5.3 Global Transdermal Drug Patches Sale Price by Application (2014-2019)
 
3 Global Transdermal Drug Patches by Players
3.1 Global Transdermal Drug Patches Sales Market Share by Players
3.1.1 Global Transdermal Drug Patches Sales by Players (2017-2019)
3.1.2 Global Transdermal Drug Patches Sales Market Share by Players (2017-2019)
3.2 Global Transdermal Drug Patches Revenue Market Share by Players
3.2.1 Global Transdermal Drug Patches Revenue by Players (2017-2019)
3.2.2 Global Transdermal Drug Patches Revenue Market Share by Players (2017-2019)
3.3 Global Transdermal Drug Patches Sale Price by Players
3.4 Global Transdermal Drug Patches Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Transdermal Drug Patches Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Transdermal Drug Patches Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
 
4 Transdermal Drug Patches by Regions
4.1 Transdermal Drug Patches by Regions
4.1.1 Global Transdermal Drug Patches Consumption by Regions
4.1.2 Global Transdermal Drug Patches Value by Regions
4.2 Americas Transdermal Drug Patches Consumption Growth
4.3 APAC Transdermal Drug Patches Consumption Growth
4.4 Europe Transdermal Drug Patches Consumption Growth
4.5 Middle East & Africa Transdermal Drug Patches Consumption Growth
 
5 Americas
5.1 Americas Transdermal Drug Patches Consumption by Countries
5.1.1 Americas Transdermal Drug Patches Consumption by Countries (2014-2019)
5.1.2 Americas Transdermal Drug Patches Value by Countries (2014-2019)
5.2 Americas Transdermal Drug Patches Consumption by Type
5.3 Americas Transdermal Drug Patches Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
 
6 APAC
6.1 APAC Transdermal Drug Patches Consumption by Countries
6.1.1 APAC Transdermal Drug Patches Consumption by Countries (2014-2019)
6.1.2 APAC Transdermal Drug Patches Value by Countries (2014-2019)
6.2 APAC Transdermal Drug Patches Consumption by Type
6.3 APAC Transdermal Drug Patches Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
 
7 Europe
7.1 Europe Transdermal Drug Patches by Countries
7.1.1 Europe Transdermal Drug Patches Consumption by Countries (2014-2019)
7.1.2 Europe Transdermal Drug Patches Value by Countries (2014-2019)
7.2 Europe Transdermal Drug Patches Consumption by Type
7.3 Europe Transdermal Drug Patches Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
 
8 Middle East & Africa
8.1 Middle East & Africa Transdermal Drug Patches by Countries
8.1.1 Middle East & Africa Transdermal Drug Patches Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Transdermal Drug Patches Value by Countries (2014-2019)
8.2 Middle East & Africa Transdermal Drug Patches Consumption by Type
8.3 Middle East & Africa Transdermal Drug Patches Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
 
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
 
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Transdermal Drug Patches Distributors
10.3 Transdermal Drug Patches Customer
 
11 Global Transdermal Drug Patches Market Forecast
11.1 Global Transdermal Drug Patches Consumption Forecast (2019-2024)
11.2 Global Transdermal Drug Patches Forecast by Regions
11.2.1 Global Transdermal Drug Patches Forecast by Regions (2019-2024)
11.2.2 Global Transdermal Drug Patches Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Transdermal Drug Patches Forecast by Type
11.8 Global Transdermal Drug Patches Forecast by Application
 
12 Key Players Analysis
12.1 Noven
12.1.1 Company Details
12.1.2 Transdermal Drug Patches Product Offered
12.1.3 Noven Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Noven News
12.2 Mylan
12.2.1 Company Details
12.2.2 Transdermal Drug Patches Product Offered
12.2.3 Mylan Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Mylan News
12.3 Novartis
12.3.1 Company Details
12.3.2 Transdermal Drug Patches Product Offered
12.3.3 Novartis Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Novartis News
12.4 Johnson & Johnson
12.4.1 Company Details
12.4.2 Transdermal Drug Patches Product Offered
12.4.3 Johnson & Johnson Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Johnson & Johnson News
12.5 Agile Therapeutics
12.5.1 Company Details
12.5.2 Transdermal Drug Patches Product Offered
12.5.3 Agile Therapeutics Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Agile Therapeutics News
12.6 Teikoku Pharma USA
12.6.1 Company Details
12.6.2 Transdermal Drug Patches Product Offered
12.6.3 Teikoku Pharma USA Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Teikoku Pharma USA News
12.7 Immune Pharmaceuticals
12.7.1 Company Details
12.7.2 Transdermal Drug Patches Product Offered
12.7.3 Immune Pharmaceuticals Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Immune Pharmaceuticals News
12.8 Hercon Pharmaceuticals
12.8.1 Company Details
12.8.2 Transdermal Drug Patches Product Offered
12.8.3 Hercon Pharmaceuticals Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Hercon Pharmaceuticals News
12.9 Pocono
12.9.1 Company Details
12.9.2 Transdermal Drug Patches Product Offered
12.9.3 Pocono Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Pocono News
12.10 DURECT Corporation
12.10.1 Company Details
12.10.2 Transdermal Drug Patches Product Offered
12.10.3 DURECT Corporation Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 DURECT Corporation News
12.11 Xel Pharmaceuticals
 
13 Research Findings and Conclusion

Related Categories
Pharmaceuticals
Related Reports
Global Tigecycline Market Insights, Forecast to 2025

Tigecycline Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the  read more..


Global Caffeine Market Insights, Forecast to 2025

Caffeine Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the forecast  read more..


Global Rabies Vaccine Market Insights, Forecast to 2025

Rabies Vaccine Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the  read more..


United States Parkinsons Disease Drug Market Report 2018-2025

The United States Parkinsons Disease Drug market research report is the study prepared by analysts, which contain a detailed analysis of drivers,  read more..


Global Radiopharmaceuticals Market Insights, Forecast to 2025

Radiopharmaceuticals Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under  read more..


Global Neurorehabilitation System Market Research Report

Neurorehabilitation system is as innovative technological solution to monitor and review the activity of nervous systems. It is a relatively new method  read more..


Global Molecular Biology Kits And Reagents Market Research Report

The global molecular biology kits and reagents market is expected to grow at a CAGR of ~7% from 2013 to 2018. A number of factors such as rise in  read more..


Global High Acuity Care Information Systems Market Research Report

The global high acuity care information systems market is expected to grow at a CAGR of ~4% from 2013 to 2018. A number of factors such as growing focus  read more..


Global Regenerative Medicine Market Research Report

The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013.   A number of factors such as increasing bone related  read more..


Global Skin Cancer Diagnostics Market Research Report

Cancers of skin tissues are one of the major types of cancers in the world. In recent years, more than 40% of all cancers in the U.S. have been skin  read more..